Portal de Periódicos da CAPES

all‐trans ‐retinoic acid in the treatment of Kimura's disease

2002; Wiley; Volume: 71; Issue: 1 Linguagem: Inglês

10.1002/ajh.10175

1096-8652

Emmanuelle Boulanger, Bertrand Gachot, Virginie Verkarre, Françoise Valensi, Nicole Brousse, Olivier Hermine,

Vascular Malformations and Hemangiomas

American Journal of HematologyVolume 71, Issue 1 p. 66-66 Letters and CorrespondenceFree Access all-trans-retinoic acid in the treatment of Kimura's disease Emmanuelle Boulanger, Emmanuelle Boulanger Department of Clinical Immunology and Hematology, Hôpital Saint-Louis, AP-HP, Paris, FranceSearch for more papers by this authorBertrand Gachot, Bertrand Gachot Department of Clinical Infectious Diseases, Institut Gustave Roussy, Villejuif, FranceSearch for more papers by this authorVirginie Verkarre, Virginie Verkarre Laboratory of Pathology, Hôpital Necker, AP-HP, Paris, FranceSearch for more papers by this authorFrançoise Valensi, Françoise Valensi Laboratory of Hematology, Hôpital Necker, AP-HP, Paris, FranceSearch for more papers by this authorNicole Brousse, Nicole Brousse Laboratory of Pathology, Hôpital Necker, AP-HP, Paris, FranceSearch for more papers by this authorOlivier Hermine, Olivier Hermine Department of Clinical Hematology, Hôpital Necker, AP-HP, Paris, FranceSearch for more papers by this author Emmanuelle Boulanger, Emmanuelle Boulanger Department of Clinical Immunology and Hematology, Hôpital Saint-Louis, AP-HP, Paris, FranceSearch for more papers by this authorBertrand Gachot, Bertrand Gachot Department of Clinical Infectious Diseases, Institut Gustave Roussy, Villejuif, FranceSearch for more papers by this authorVirginie Verkarre, Virginie Verkarre Laboratory of Pathology, Hôpital Necker, AP-HP, Paris, FranceSearch for more papers by this authorFrançoise Valensi, Françoise Valensi Laboratory of Hematology, Hôpital Necker, AP-HP, Paris, FranceSearch for more papers by this authorNicole Brousse, Nicole Brousse Laboratory of Pathology, Hôpital Necker, AP-HP, Paris, FranceSearch for more papers by this authorOlivier Hermine, Olivier Hermine Department of Clinical Hematology, Hôpital Necker, AP-HP, Paris, FranceSearch for more papers by this author First published: 03 September 2002 https://doi.org/10.1002/ajh.10175Citations: 19AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1Li TJ, Chen XM, Wang SZ, Fan MW, Semba I, Kitano M. Kimura's disease: a clinicopathologic study of 54 Chinese patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 82: 549– 555. 2Belaich S, Crickx B, Grossin M, Leroy D. Kimura's disease: treatment with etretinate. XVII Congressus mundi Dermatologiae, Berlin, May 24–29, 1987. 3Inoue C, Ichikawa A, Hotta T, Saito H. Constitutive gene expression of interleukin-5 in Kimura's disease. Br J Haematol 1990; 76: 554– 559. 4Katagiri K, Itami S, Hatano Y, Yamaguchi T, Takayasu S. In vivo expression of IL-4, IL-5, IL-13 and IFN-γ mRNAs in peripheral blood mononuclear cells and effect of cyclosporin A in a patient with Kimura's disease. Br J Dermatol 1997; 137: 972– 977. 5Worm M, Krah JM, Manz RA, Henz BM. Retinoic acid inhibits CD40+ interleukin-4-mediated IgE production in vitro. Blood 1998; 92: 1713– 1720. Citing Literature Volume71, Issue1September 2002Pages 66-66 ReferencesRelatedInformation